HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin C COVID-19 'Cure' Claims Not Getting Past ASA

Executive Summary

UK advertising watchdog ASA reprimands Revival Drinks for social media posts which claimed its vitamin C supplement could cure COVID-19.

You may also be interested in...



COVID-19 Mentions Prohibited From Supplement Ads - UK Regulator

Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.

UK Industry Welcomes Coronavirus Responsible Advertising Guidelines

UK industry association, PAGB, welcomes a clarification from the country's advertising standards authority on how consumer healthcare products should be advertised during the Covid-19 pandemic.

Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories

Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel